Re: Impact of ABO Blood Type on Outcomes in Patients with Primary Nonmuscle Invasive Bladder Cancer Klatte T, Xylinas E, Rieken M, et al.

Massimo Franchini, Emmanuel J. Favaloro, Giovanni Targher, Giuseppe Lippi, ABO blood group, hypercoagulability, and cardiovascular and cancer risk Critical Reviews in Clinical Laboratory Sciences. ,vol. 49, pp. 137- 149 ,(2012) , 10.3109/10408363.2012.708647

K. Viskum, The ABO and rhesus blood groups in patients with pulmonary tuberculosis Tubercle. ,vol. 56, pp. 329- 334 ,(1975) , 10.1016/0041-3879(75)90089-6

Tobias Klatte, Evanguelos Xylinas, Malte Rieken, Morgan Rouprêt, Harun Fajkovic, Christian Seitz, Pierre I. Karakiewicz, Yair Lotan, Marko Babjuk, Michela de Martino, Shahrokh F. Shariat, Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urologic Oncology-seminars and Original Investigations. ,vol. 32, pp. 625- 630 ,(2014) , 10.1016/J.UROLONC.2013.11.010

Per-Uno Malmström, Christer Busch, Bo Johan Norlen, Bertil Andersson, Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma Scandinavian Journal of Urology and Nephrology. ,vol. 22, pp. 265- 270 ,(1988) , 10.3109/00365598809180797

Torben F. Ørntoft, Peter Meldgaard, Hans Wolf, Bent Pedersen, The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Research. ,vol. 56, pp. 1031- 1036 ,(1996)